INSIGHTS ON DRUG DEVELOPMENT

• A Universal Workflow Approach For Single Cell Mass Spectrometry Based Proteomics

  Learn about a streamlined workflow that improves reproducibility, reduces contamination, and simplifies single-cell proteomics with comparable results to FACS.

• From Sequence To Scale In Seven Months

  Accelerate recombinant protein development from sequence to scale while maintaining stable expression, manufacturing efficiency, and critical quality attributes.

• Temperature Dependence On Reversed-Phase Separations

  Column temperature critically affects the reversed-phase separation of fatty acid-modified GLP-1 RAs and impurities. Learn how precise control enhances resolution and reproducibility.

• Ask Us Anything: Michael Tracey On DoE In Process Characterization

  Insights into the validation expertise behind process characterization and how deep problem-solving can turn a process into one robust enough to carry a drug to market.

• Cell Culture Automation Of The 3D Cancer Spheroid Assay

  3/24/2025

  Discover how automated 3D cell culture methods enhance efficiency and consistency in high-throughput drug screening to accelerate the discovery of new anti-cancer therapies.

• Solubility And Improved Patient Outcomes

  9/9/2026

  Poor solubility poses major development challenges. Innovative formulation technologies and careful excipient selection can improve bioavailability and product performance.

• High-Sensitivity IVT mRNA Analysis

  2/20/2025

  Quality analysis of in vitro transcribed (IVT) has become an essential part of biotherapeutic workflows. Discover a high-sensitivity kit made for analyzing IVT mRNA quality to advance your research.

• Microflow Columns Boost GLP-1 Sensitivity And Reduce Solvent

  5/7/2026

  Microflow chromatography offers a practical way to boost GLP‑1 assay sensitivity while cutting solvent use. See how 1.0 mm columns improve peak response without sacrificing chromatographic performance.

• Evolving Gene Editing For Rare Disease Drug Development

  10/9/2025

  Explore how scalable gene editing platforms are advancing therapies for ultra-orphan conditions, with insights into manufacturing models, regulatory strategies, and clinical approaches.